These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Immunosuppression--a tightrope walk between iatrogenic harm and therapy]. Berchtold P; Seitz M Schweiz Med Wochenschr; 1996 Sep; 126(38):1603-9. PubMed ID: 8927965 [TBL] [Abstract][Full Text] [Related]
3. [Molecular mechanisms of action of some immunosuppressive drugs]. Liberman AC; Druker J; Refojo D; Arzt E Medicina (B Aires); 2008; 68(6):455-64. PubMed ID: 19147430 [TBL] [Abstract][Full Text] [Related]
4. [The combination of cyclosporin A and fluocortolone in the treatment of autoimmune diseases]. Aresu G; Pascalis L; Pia G Clin Ter; 1989 Oct; 131(1):3-21. PubMed ID: 2531058 [TBL] [Abstract][Full Text] [Related]
6. Clinically validated approaches to the treatment of autoimmune diseases. Carter PH; Zhao Q Expert Opin Investig Drugs; 2010 Feb; 19(2):195-213. PubMed ID: 20050823 [TBL] [Abstract][Full Text] [Related]
7. B cells as a therapeutic target in autoimmune diseases other than rheumatoid arthritis. Looney RJ Rheumatology (Oxford); 2005 May; 44 Suppl 2():ii13-ii17. PubMed ID: 15851522 [TBL] [Abstract][Full Text] [Related]
8. [Immunosuppressive treatment after organ transplantation]. Niaudet P Arch Fr Pediatr; 1988; 45 Suppl 1():741-4. PubMed ID: 3240052 [TBL] [Abstract][Full Text] [Related]
10. Animal models of endocrine/organ-specific autoimmune diseases: do they really help us to understand human autoimmunity? Lam-Tse WK; Lernmark A; Drexhage HA Springer Semin Immunopathol; 2002 Dec; 24(3):297-321. PubMed ID: 12503056 [TBL] [Abstract][Full Text] [Related]
11. [Immunosuppressive drugs and autoimmune diseases]. Rossert J; Druet P Ann Biol Clin (Paris); 1991; 49(6):327-37. PubMed ID: 1759727 [TBL] [Abstract][Full Text] [Related]
12. Treating autoimmune diseases through restoration of antigen-specific immune tolerance. Wolfraim LA Arch Immunol Ther Exp (Warsz); 2006; 54(1):1-13. PubMed ID: 16642252 [TBL] [Abstract][Full Text] [Related]
14. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626 [TBL] [Abstract][Full Text] [Related]
15. Cyclophosphamide as alternative immunosuppressive therapy for autoimmune hepatitis--report of three cases. Kanzler S; Gerken G; Dienes HP; Meyer zum Büschenfelde KH; Lohse AW Z Gastroenterol; 1997 Jul; 35(7):571-8. PubMed ID: 9273991 [TBL] [Abstract][Full Text] [Related]
16. Interferon alpha and its contribution to autoimmunity. Selmi C; Lleo A; Zuin M; Podda M; Rossaro L; Gershwin ME Curr Opin Investig Drugs; 2006 May; 7(5):451-6. PubMed ID: 16729722 [TBL] [Abstract][Full Text] [Related]
17. [Treatment of autoimmune diseases]. Moeschlin S Schweiz Med Wochenschr; 1971 Oct; 101(39):1393-9. PubMed ID: 4401236 [No Abstract] [Full Text] [Related]
18. Tolerogenic antibodies and fusion proteins to prevent graft rejection and treat autoimmunity. Chatenoud L Mol Med Today; 1998 Jan; 4(1):25-30. PubMed ID: 9494967 [TBL] [Abstract][Full Text] [Related]
19. Use of intravenous immunoglobulin therapy in autoimmune blistering diseases. Ahmed AR Int Immunopharmacol; 2006 Apr; 6(4):557-78. PubMed ID: 16504919 [TBL] [Abstract][Full Text] [Related]
20. Autoimmune manifestations during interferon therapy in patients with chronic hepatitis C: the hepatologist's view. Pellicano R; Smedile A; Peyre S; Astegiano M; Saracco G; Bonardi R; Rizzetto M Minerva Gastroenterol Dietol; 2005 Mar; 51(1):55-61. PubMed ID: 15756146 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]